Skip to main navigation
  • Company
    • About Us
    • Leadership
    • Collaboration
    • Contact
  • Pipeline
    • Pipeline
    • Clinical Trials
  • Patients
  • Technology
    • Multiclonics® Platform
    • Publications
  • Investors & Media
    • Investors & Media Home
    • Financial Information
      • SEC Filings
      • Extraordinary General Meeting December 2019
      • Annual General Meeting 2022
      • Annual General Meeting 2021
      • Extraordinary General Meeting December 2019
      • Annual General Meeting 2019
      • Annual General Meeting 2018
      • Annual General Meeting 2017
    • Corporate Governance
      • Management Team
      • Board of Directors
      • Committee Composition
      • Governance Contacts
      • Governance Documents
    • News Releases
    • Event Calendar
    • Analyst Coverage
    • Stock Information
    • FAQ's
    • Email Alerts
  • Careers
Menu
 

Extraordinary General Meeting December 2019

SubNav - Financial Information

  • SEC Filings
  • Extraordinary General Meeting December 31, 2019
  • Extraordinary General Meeting December 2019
  • Annual General Meeting 2022
  • Annual General Meeting 2021
  • Annual General Meeting 2020
  • Annual General Meeting 2019
  • Annual General Meeting 2018
  • Annual General Meeting 2017

Extraordinary General Meeting December 2019

Minutes 2019 EGM - Merus N.V.
December 6, 2019
Merus N.V. - Voting Results (EGM December 2019)
December 6, 2019
Convening Notice with Agenda and Explanatory Notes (EGM 2019)
November 18, 2019
Proposed Articles of Association - Merus N.V.
November 18, 2019
Merus N.V. - Voting Proxy (EGM 2019)
November 18, 2019

Toolkit

  • RSS Feeds
  • E-mail Page
  • Print Page
  • E-mail Alerts
Explore
  • Company
  • Pipeline
  • Patients
  • Technology
  • Investors & Media
  • Careers
  • Contact
Contact Us

NL: +31 85 016 2500
Merus N.V., Uppsalalaan 17, 3rd & 4th floor, 3584 CT Utrecht, The Netherlands
US: +1 617 401 4499
139 Main Street, Cambridge, MA 02142, USA
enquiries@merus.nl

© 2023 Merus - All rights reserved. Privacy Statement, Online Tracking Opt-Out Guide, Terms of Use & Community Guidelines.